HDAC-8 inhibitors (Boston University/Dana-Farber)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHDAC-8 inhibitors (Boston University/Dana-Farber)
Drug Alias NameHDAC-8 inhibitors (Boston University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 8 inhibitors
TargetsHistone deacetylase 8
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBoston University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteBoston University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A